These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14966174)

  • 1. Coexistent blepharospasm and hemifacial spasm: overlapping pathophysiologic mechanism?
    Tan EK; Chan LL; Koh KK
    J Neurol Neurosurg Psychiatry; 2004 Mar; 75(3):494-6. PubMed ID: 14966174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facial dystonias and rosacea: is there an association?
    Khan TT; Donaldson J; Hesse RJ
    Orbit; 2014 Aug; 33(4):276-9. PubMed ID: 24831933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm.
    Cannon PS; MacKenzie KR; Cook AE; Leatherbarrow B
    Clin Exp Ophthalmol; 2010 Oct; 38(7):688-91. PubMed ID: 20456439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grey Matter Microstructural Integrity Alterations in Blepharospasm Are Partially Reversed by Botulinum Neurotoxin Therapy.
    Alexandru H; Muthuraman M; Chirumamilla VC; Koirala N; Paktas B; Deuschl G; Zeuner KE; Groppa S
    PLoS One; 2016; 11(12):e0168652. PubMed ID: 27992533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign essential blepharospasm: risk factors with reference to hemifacial spasm.
    Hall TA; McGwin G; Searcey K; Xie A; Hupp SL; Owsley C; Kline LB
    J Neuroophthalmol; 2005 Dec; 25(4):280-5. PubMed ID: 16340493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Closely spaced stressful life events precede the onset of benign essential blepharospasm and hemifacial spasm.
    Johnson LN; Lapour RW; Johnson GM; Johnson PJ; Madsen RW; Hackley SA
    J Neuroophthalmol; 2007 Dec; 27(4):275-80. PubMed ID: 18090560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative absence of psychopathology in benign essential blepharospasm and hemifacial spasm.
    Scheidt CE; Schuller B; Rayki O; Kommerell G; Deuschl G
    Neurology; 1996 Jul; 47(1):43-5. PubMed ID: 8710122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Young onset hemifacial spasm.
    Tan EK; Chan LL
    Acta Neurol Scand; 2006 Jul; 114(1):59-62. PubMed ID: 16774629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review of Tolerance and Safety Profiles of Long-Term Botulinum Neurotoxin Type A in Asian Patients with Hemifacial Spasm and Benign Essential Blepharospasm.
    Lai KKH; Tsang A; Kuk AKT; Ko CKL; Chan E; Ko STC
    Neuroophthalmology; 2021; 45(5):293-300. PubMed ID: 34566211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of bangerter occlusion foils on blepharospasm and hemifacial spasm in occlusion-positive and occlusion-negative patients.
    Malhotra R; Then SY; Richards A; Cheek E
    Open Ophthalmol J; 2010 Jan; 4():1-6. PubMed ID: 20148097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher prevalence of obsessive-compulsive symptoms in patients with blepharospasm than in patients with hemifacial spasm.
    Broocks A; Thiel A; Angerstein D; Dressler D
    Am J Psychiatry; 1998 Apr; 155(4):555-7. PubMed ID: 9546005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative crossover study on the treatment of hemifacial spasm and blepharospasm: preseptal and pretarsal botulinum toxin injection techniques.
    Lolekha P; Choolam A; Kulkantrakorn K
    Neurol Sci; 2017 Nov; 38(11):2031-2036. PubMed ID: 28884242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase lipid tear thickness after botulinum neurotoxin A injection in patients with blepharospasm and hemifacial spasm.
    Ho RW; Fang PC; Chao TL; Chien CC; Kuo MT
    Sci Rep; 2018 May; 8(1):8367. PubMed ID: 29849166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case control MR-CISS and 3D TOF MRA imaging study of medullary compression and hypertension in hemifacial spasm.
    Chan LL; Lee E; Fook-Chong S; Tan EK
    Mov Disord; 2008 Oct; 23(13):1820-4. PubMed ID: 18709669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life and psychosocial characteristics of patients with benign essential blepharospasm.
    Hall TA; McGwin G; Searcey K; Xie A; Hupp SL; Owsley C; Kline LB
    Arch Ophthalmol; 2006 Jan; 124(1):116-9. PubMed ID: 16401794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm.
    Wu CJ; Shen JH; Chen Y; Lian YJ
    Turk Neurosurg; 2011; 21(4):625-9. PubMed ID: 22194126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asynchronous blepharospasm, facial and cervical dystonia, and bilateral asynchronous hemifacial spasm.
    Katz BJ; Burroughs JR; Anderson RL; Bownds S; McCann JD
    Mov Disord; 2007 Jan; 22(2):231-4. PubMed ID: 17133455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between reflex excitability and symptom duration in hemifacial spasm.
    Uzun N; Erdemir-Kiziltan M; Karaali-Savrun F
    Electromyogr Clin Neurophysiol; 2005; 45(1):33-7. PubMed ID: 15773262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Writing, reading, and speaking in blepharospasm.
    Ferrazzano G; Conte A; Belvisi D; Fabbrini A; Baione V; Berardelli A; Fabbrini G
    J Neurol; 2019 May; 266(5):1136-1140. PubMed ID: 30783748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventrolateral medullary compression in hypertensive patients with hemifacial spasm.
    Chan LL; Lo YL; Lee E; Fook-Chong S; Tan EK
    Neurology; 2005 Nov; 65(9):1467-70. PubMed ID: 16275838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.